Novartis names AbbVie’s Patrick Horber as President, International

Novartis (NVS) announced that Marie-France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, has decided to leave the company and will step down from the Executive Committee of Novartis, effective September 15, after nearly seven years of commercial leadership at Novartis. Patrick Horber, M.D., currently Senior Vice President and President, Immunology at AbbVie (ABBV), has been appointed as President, International, effective later this year, reporting to Vas Narasimhan, M.D., CEO of Novartis. Horber will become a member of the ECN. Mukul Mehta, CFO, International, will lead the unit ad-interim until Horber assumes the role.